Trends in the incidence of urothelial carcinoma in Taiwan after the ban on aristolochic acid-containing Chinese herbal preparations, 2001–2018: a national population-based cohort study-Reference-Cited by-同舟云学术

Trends in the incidence of urothelial carcinoma in Taiwan after the ban on aristolochic acid-containing Chinese herbal preparations, 2001–2018: a national population-based cohort study

Published:2023-04-15 Issue:11 Volume:149 Page:8201-8211
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Liao Cheng-I.,Fang Hua-Chang,Lee Po-Tsang,Hsu Chih-Yang,Chen Chien-Liang,Huang Chien-Wei,Chen Xin-You,Ou Shih-Hsiang,Tsai Chun-Teng,Chou Kang-Ju

Funder

Kaohsoung Veterans General Hospital

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-04771-6.pdf

Reference53 articles.

1. Abdullah R, Diaz LN, Wesseling S, Rietjens IM (2016) (2017) Risk assessment of plant food supplements and other herbal products containing aristolochic acids using the margin of exposure (MOE) approach. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 34(2):135–144. https://doi.org/10.1080/19440049.2016.1266098

2. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M et al (2018) Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391(10125):1023–1075. https://doi.org/10.1016/s0140-6736(17)33326-3

3. Aly A, Johnson C, Doleh Y, Chirikov V, Botteman M, Shenolikar R et al (2020) The real-world lifetime economic burden of urothelial carcinoma by stage at diagnosis. J Clin Pathw 6(4):51–60

4. Al-Zoughool M, Bird M, Rice J, Baan RA, Billard M, Birkett N et al (2019) Development of a database on key characteristics of human carcinogens. J Toxicol Environ Health B Crit Rev 22(7–8):264–287. https://doi.org/10.1080/10937404.2019.1642593

5. Bree KK, Shan Y, Hensley PJ, Lobo N, Hu C, Tyler DS et al (2022) Management, surveillance patterns, and costs associated with low-grade papillary stage ta non-muscle-invasive bladder cancer among older adults, 2004–2013. JAMA Netw Open 5(3):e223050. https://doi.org/10.1001/jamanetworkopen.2022.3050

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term oral administration of Kelisha capsule does not cause hepatorenal toxicity in rats;Journal of Ethnopharmacology;2024-10

2. Comprehensive HRMS Screening and Risk Assessments of Aristolochic Acid Analogues in Asari Radix et Rhizoma and Related Commercial Health Products;Journal of Agricultural and Food Chemistry;2024-03-21

3. Reduced burden of Arsenic-Related cancers after water mitigation in Taiwan;Environment International;2024-03

4. Upper Tract Urothelial Carcinoma (UTUC) Diagnosis and Risk Stratification: A Comprehensive Review;Cancers;2023-10-14